These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4691232)

  • 21. A new antibody, anti-Fy3, in the Duffy blood group system.
    Albrey JA; Vincent EE; Hutchinson J; Marsh WL; Allen FH; Gavin J; Sanger R
    Vox Sang; 1971 Jan; 20(1):29-35. PubMed ID: 5553616
    [No Abstract]   [Full Text] [Related]  

  • 22. Occurrence of antibodies to low-incidence antigens among a cohort of multiply transfused patients with sickle cell disease.
    Jackson P
    Immunohematology; 2011; 27(4):143-5. PubMed ID: 22822516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alloimmunization in poly-transfused patients with hemoglobin S disease].
    Gómez Oliva P; Basanta Otero P; González Villalonga C; Batista Veranes M; Orbeal Aldama L; García Echevarría M
    Sangre (Barc); 1985; 30(4-A):406-10. PubMed ID: 4071354
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-Fy3 in sickle cell disease: a difficult transfusion problem.
    Went R; Wright J; Webster R; Stamps R
    Br J Haematol; 2009 Feb; 144(4):621-2. PubMed ID: 19055658
    [No Abstract]   [Full Text] [Related]  

  • 25. [Unusual Duffy system antibodies in a female patient with a blood transfusion complication].
    Umnova MA; Skachilova NN; Piskunova TM; Ichalovskaia TA; Oshkina NP
    Probl Gematol Pereliv Krovi; 1977 Dec; 22(12):38-40. PubMed ID: 600940
    [No Abstract]   [Full Text] [Related]  

  • 26. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
    Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Fy5, and antibody disclosing a probable association between the Rhesus and Duffy blood group genes.
    Colledge KI; Pezzulich M; Marsh WL
    Vox Sang; 1973 Mar; 24(3):193-9. PubMed ID: 4632152
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparison of autoanalyzer and manual methods for red cell antibody screening.
    Morehead RT; Anderson K; Grunewald S; Casey D; McCullough J
    Transfusion; 1974; 14(6):586-9. PubMed ID: 4432262
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood transfusion complications due to Duffy factor (Fya) incompatibility].
    Umnova MA; Skachilova NN; Piskunova TM; Molchanova NP; Shakhsuvarov VD
    Probl Gematol Pereliv Krovi; 1982 Dec; 27(12):11-5. PubMed ID: 7156083
    [No Abstract]   [Full Text] [Related]  

  • 30. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion.
    Ameen R; Al Shemmari S; Al-Bashir A
    Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The frequency of irregular erythrocyte antibodies (author's transl)].
    Maurer C; Büttner J
    Dtsch Med Wochenschr; 1975 Jul; 100(30):1567-70, 1573. PubMed ID: 808403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In search of red blood cells for alloimmunized patients with sickle cell disease.
    Flickinger C
    Immunohematology; 2006; 22(3):136-42. PubMed ID: 17105363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance.
    Castellino SM; Combs MR; Zimmerman SA; Issitt PD; Ware RE
    Br J Haematol; 1999 Jan; 104(1):189-94. PubMed ID: 10027733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isoantibodies to human IgM: serologic and immunochemical investigations.
    Leikola J; Fudenberg HH; Vyas GN; Perkins HA
    J Immunol; 1971 May; 106(5):1147-53. PubMed ID: 4995748
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular biology of the Rh system: clinical considerations for transfusion in sickle cell disease.
    Chou ST; Westhoff CM
    Hematology Am Soc Hematol Educ Program; 2009; ():178-84. PubMed ID: 20008197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relevance of RH variants in transfusion of sickle cell patients.
    Noizat-Pirenne F; Tournamille C
    Transfus Clin Biol; 2011 Dec; 18(5-6):527-35. PubMed ID: 22024128
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Red cell alloimmunization in sickle cell disease.
    Davies SC; McWilliam AC; Hewitt PE; Devenish A; Brozovic M
    Br J Haematol; 1986 Jun; 63(2):241-5. PubMed ID: 3087406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relevance of alloimmunization in haemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F
    Transfus Clin Biol; 2012 Jun; 19(3):132-8. PubMed ID: 22818360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alloimmunization to red blood cell antigens by transfusion.
    Mintz PD
    Blood; 2010 May; 115(21):4315; author reply 4315-6. PubMed ID: 20508173
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinically significant and insignificant antibodies in blood transfusion.
    Morel PA; Garratty G; Perkins HA
    Am J Med Technol; 1978 Feb; 44(2):122-9. PubMed ID: 414622
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.